期刊文献+

高效液相质谱联用法测定人血浆中蒿甲醚及其活性代谢物双氢青蒿素的浓度(英文) 被引量:3

Determination of artemether and its metabolite dihydroartemisinin in human plasma by HPLC with atmospheric pressure chemical ionization mass spectrometry
下载PDF
导出
摘要 目的建立高效液相质谱联用法以测定人血浆中蒿甲醚(ARM)及其活性代谢物双氢青蒿素(DHA)的浓度.方法色谱条件:色谱柱为C18(150 mm×4.6 mm,5μm),流动相为0.2%醋酸-甲醇梯度洗脱系统,流速为1.0 mL·min-4.质谱条件:大气压化学电离方法(APCI)采集正离子,SIM方式对ARM和DHA检测m/z 221,对内标(青蒿素)检测m/z 283.血浆样品的预处理采用甲基叔丁基醚萃取法.结果ARM和DHA的线性范围为5~300μg·L-1,相关系数r>0.999 0,检测限均为2μg·L-11.ARM和DHA日内和日间测定的RSD<9.3%,回收率在92%~105%的范围内,提取回收率为80%~96%.结论该法简便、准确、灵敏、专属,适用于ARM和DHA的人体药动学研究. AIM To develop a HPLC-MS method for the determination of ARM and its active metabolite DHA in human plasma. METHODS The chromatography separation was performed on a C18 column (150 mm × 4.6 mm, 5 μm) with a gradient elution mobile phase consisting of 0.2 % glacial acetic acid aqueous solution and methanol at a flow rate of 1.0 mL·min^-1 .MS detection in SIM mode using APCI as an interface was applied to determine positive ions at m/z 221 for ARM and DHA, and m/z 283 for internal standard (artemisinin). Plasma samples were extracted with methyl t- butyl ether, followed by evaporation of the supernatant to dryness and reconstitution of the residue in methanol. RESULTS High specificity and a low detection limit (2 μg· L^-1) were achieved for ARM and DHA. Linearity was confirmed in the concentration range of 5 -300 μg· L^-1 with the correlation coefficient (r) 〉 0.999 0. The RSD values of intra - and inter-day assay for both compounds were less than 9.3 % and the recoveries were within 92 % - 105 % . The extraction recovery of ARM and DHA ranged from 80% to 96%. CONCLUSION The tive and can be applicable to pharmacokinetic studies of ARM and DHA in method proves to be simple, accurate, sensi- humans.
出处 《中国临床药学杂志》 CAS 2005年第5期274-278,共5页 Chinese Journal of Clinical Pharmacy
关键词 蒿甲醚 双氢青蒿素 高效液相质谱联用法 artemether dihydroartemisinin high-performance liquid chromatography-mass spectrometry
  • 相关文献

参考文献9

  • 1张志荣,胡海燕,洪诤,邱加闽,何金戈,黄民贵.蒿甲醚缓释片在狗体内的药代动力学[J].华西药学杂志,2000,15(5):335-337. 被引量:6
  • 2De Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria [J]. Drugs, 1996, 52(6): 818.
  • 3Hien TT, Davis TM, Chuong LV, et al. Comparative pharmacokineticsof intramuscular artesunate and artemether in patients with severe falciparum malaria [J]. Antimicrob Agents Chemother, 2004, 48 ( 11 ): 4234.
  • 4Batty KT, Davis TME, Thu LTA, et al. Selective high-performance liquid chromatographic determination of artesunate and alpha-and beta-dihydroartemisinin in patients with falciparum malaria [J]. J Chromatogr B, 1996, 677(2): 345.
  • 5Karbwang J, Na-Bangchang K, Molunto P, et al. Determination ofartemether and its major metabolite, dihydroartemisinin in plasma using high performance liquid chromatography with electrochemical detection [J]. J Chromatogr, 1997, 690(1-2):259.
  • 6Souppart C, Gauducheau N, Sandrenan N, et al. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihy droartemisinin in human plasma [J]. J Chromatog B, 2002, 774(2):195.
  • 7Green MD, Mount DL, Todd GD, et al. Chemiluminescent detection of artemisinin novel endoperoxide analysis using luminol with hydrogen peroxide [J]. J Chromatogr A, 1995, 695(6): 237.
  • 8Mohamed SS, Khalid SA, Ward SA, et al. Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring [J]. J Chromatogr B, 1999, 731(2) :251.
  • 9Mithwani S, Aarons L, Kokwaro GO, et al. Population pharmacokinet ics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria. Br J Clin Pharmacol, 2004, 57(2) :146.

二级参考文献2

共引文献5

同被引文献101

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部